Connect with us


5 of the latest cardiac tech insights out of ACC.21 | Page 5 of 6 | Medical Design and Outsourcing – Medical Design & Outsourcing

The American College of Cardiology’s 70th Annual Scientific Session has produced some positive news about some controversial cardiac tech.



Article feature image

Cook Medical’s Zilver PTX Drug-Eluting Stent is intended to treat peripheral arterial disease (PAD) in the superficial femoral artery.
An analysis of 168,553 Medicare recipients who underwent femoropopliteal artery revascularization from 2015 through 2018 showed the weighted cumulative incidence of mortality at 5 years was 53.8% among those treated with drug-coated devices and 55.1% among those treated with nondrug-coated devices.
Paclitaxel-coated devices took a hit following an August 2019 FDA…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Plant-based diet appears to offer protection against hypertension and preeclampsia – News-Medical.Net
Article feature image
Victoria COVID live updates: Active coronavirus cases drop; Pfizer vaccination walk-ins paused – Brisbane Times